Bhatia Neal, Berman Brian, Ceilley Roger I, Kircik Leon H
J Drugs Dermatol. 2017 May 1;16(5):61-66.
The limitations of photoprotection modalities have been the inability to arrest the progression of photodamage. Chemoprevention strategies involving a sunscreen has been incomplete because of the need to induce sustained repair of mutations and slow carcinogenesis. Photolyases, or photoreactivation enzymes, serve the role of repairing mutations and damage to DNA induced by ultraviolet (UV) radiation and therefore influence the initiation phases of carcinogenesis. As these enzymes are absent in humans, exogenous forms have been manufactured and are now utilized in topical agents to supplement and augment the innate repair mechanisms that are mostly inefficient. J Drugs Dermatol. 2017;16(5 Suppl):61-66.
光防护方式的局限性在于无法阻止光损伤的进展。由于需要诱导对突变的持续修复并减缓致癌作用,涉及防晒霜的化学预防策略并不完善。光解酶,即光复活酶,起到修复由紫外线(UV)辐射诱导的DNA突变和损伤的作用,因此会影响致癌作用的起始阶段。由于人类体内不存在这些酶,已制造出其外源形式,目前用于局部用药,以补充和增强大多效率低下的固有修复机制。《皮肤药物学杂志》。2017年;16(5增刊):61 - 66。